Elanco Animal Health Inc (NYSE:ELAN)’s traded shares stood at 1.39 million during the latest session, with the company’s beta value hitting 1.68. At the last check today, the stock’s price was $13.84, to imply a decrease of -2.36% or -$0.33 in intraday trading. The ELAN share’s 52-week high remains $18.55, putting it -34.03% down since that peak but still an impressive 42.05% since price per share fell to its 52-week low of $8.02.
Analysts have given a consensus recommendation of Buy for Elanco Animal Health Inc (ELAN), translating to a mean rating of 1.79. Of 5 analyst(s) looking at the stock, 1 analyst(s) give ELAN a Sell rating. 0 of those analysts rate the stock as Overweight while 1 advise Hold as 3 recommend it as a Buy.
Elanco Animal Health Inc (NYSE:ELAN) trade information
After registering a -2.36% downside in the latest session, Elanco Animal Health Inc (ELAN) has traded red over the past five days. The 5-day price performance for the stock is -0.47%, and 7.41% over 30 days. With these gigs, the year-to-date price performance is 14.24%.
The extremes give us $11 and $12 for target low and target high price respectively. As such, ELAN has been trading 13.29% off suggested target high and 20.52% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 29.95% for the past 5-year period. While 2025 is set for a -7.67% return in earnings, projections for the next 5 years are at 6.04% annually.
ELAN Dividends
Elanco Animal Health Inc has its next earnings report out in July. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
The next major institution holding the largest number of shares is PRIMECAP MANAGEMENT CO/CA/ with 52.8 million shares, or about 10.6845% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $761.94 million.
We also have Dodge & Cox Funds-Dodge & Cox Stock Fund and VANGUARD CHESTER FUNDS-Vanguard PRIMECAP Fund as the top two Mutual Funds with the largest holdings of the Elanco Animal Health Inc (ELAN) shares. Going by data provided on Mar 31, 2025 , Dodge & Cox Funds-Dodge & Cox Stock Fund holds roughly 55.34 shares. This is just over 11.14% of the total shares, with a market valuation of $768.14 million. Data from the same date shows that the other fund manager holds a little less at 18.91, or 3.81% of the shares, all valued at about 262.53 million.
